small molecule

WYNZORA

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE

Loss of exclusivityMarch 2039latest FDA-listed patent expiry

CompanyMc2,Inc. →View the full company profile on CliffBio

Drug detail

Brand name	WYNZORA
Active ingredient	BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Strength	0.064%;0.005%
Dosage form	CREAM
Route	TOPICAL
Modality	Small molecule
FDA approval	July 2020
Marketing status	RX

Listed patents

Patent	Expires	Type
12440499	March 2039	product
11696919	March 2039	product
10265265	September 2027	product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.